Detalhe da pesquisa
1.
RB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106.
Br J Haematol
; 176(5): 759-769, 2017 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-27992063
2.
Increased numbers of CD23(+) CD21(hi) Bin-like B cells in human reactive and rheumatoid arthritis lymph nodes.
Eur J Immunol
; 46(7): 1752-7, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27105894
3.
Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601.
Br J Haematol
; 172(2): 208-18, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26492567
4.
Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma.
Blood
; 124(8): 1259-65, 2014 Aug 21.
Artigo
Inglês
| MEDLINE | ID: mdl-25016003
5.
The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives.
Blood
; 119(14): 3321-9, 2012 Apr 05.
Artigo
Inglês
| MEDLINE | ID: mdl-22323447
6.
Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.
Blood
; 117(2): 530-41, 2011 Jan 13.
Artigo
Inglês
| MEDLINE | ID: mdl-20962324
7.
Follicular lymphoma tumor-infiltrating T-helper (T(H)) cells have the same polyfunctional potential as normal nodal T(H) cells despite skewed differentiation.
Blood
; 118(13): 3591-602, 2011 Sep 29.
Artigo
Inglês
| MEDLINE | ID: mdl-21821704
8.
The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma.
Blood
; 117(10): 2807-12, 2011 Mar 10.
Artigo
Inglês
| MEDLINE | ID: mdl-21239695
9.
Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic era.
Biol Blood Marrow Transplant
; 18(4): 640-7, 2012 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-21871246
10.
A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection.
Biol Blood Marrow Transplant
; 17(7): 1033-42, 2011 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-21074630
11.
Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximab.
Blood
; 113(16): 3809-12, 2009 Apr 16.
Artigo
Inglês
| MEDLINE | ID: mdl-19196657
12.
Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness.
J Immunol
; 183(10): 6157-66, 2009 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-19864600
13.
Peroxisome proliferator-activated receptor gamma overexpression and knockdown: impact on human B cell lymphoma proliferation and survival.
Cancer Immunol Immunother
; 58(7): 1071-83, 2009 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-19018532
14.
Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cells.
Clin Cancer Res
; 14(20): 6414-25, 2008 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-18927280
15.
The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and its derivatives elicit human lymphoid cell apoptosis through a novel pathway involving the unregulated mitochondrial permeability transition pore.
Cancer Res
; 67(4): 1793-802, 2007 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-17308122
16.
The Fast Real-time Assessment of Combination Therapies in Immuno-ONcology (FRACTION) program: innovative, high-throughput clinical screening of immunotherapies.
Eur J Cancer
; 103: 259-266, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30292142
17.
Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer.
Front Immunol
; 9: 1613, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30123214
18.
Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma.
Clin Cancer Res
; 24(24): 6150-6159, 2018 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30082475
19.
Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies.
Immunol Invest
; 36(5-6): 629-48, 2007.
Artigo
Inglês
| MEDLINE | ID: mdl-18161522
20.
The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) induces apoptosis of human diffuse large B-cell lymphoma cells through a peroxisome proliferator-activated receptor gamma-independent pathway.
Exp Hematol
; 34(9): 1202-11, 2006 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-16939813